US OTC Pharmaceutical Market Guide
The US OTC industry is expected to have a market value of $31.9 billion by the end of 2014. In this research report, you’ll learn about the U.S. OTC Pharmaceutical Market’s competitive landscape, market share and industry segmentation in this research report.
The United States is a large market for OTC pharmaceuticals, and it is regulated by the Food and Drug Administration (FDA). While the laws governing OTC pharmaceuticals are very strict, the market itself has grown over the years and has many major players operating in the industry.
With market growth mitigating rivalry in the pharma market, manufacturers are focusing on product differentiation in order to make a niche for themselves. This report includes provides a SWOT analysis and product offerings of major industry players including Bristol Myers Squibb, Novartis, Bayer, GlaxoSmithKline, and many others.
With the global OTC pharmaceuticals industry expected to grow at a moderate pace in the coming years, the U.S. OTC pharmaceuticals market is also looking for a decelerated growth till the year 2014.
This research report on the U.S. OTC Pharmaceutical Market analyzes this high-growth industry’s market value and competitive landscape, and includes a U.S. OTC Drug Monograph.
The United States is a large market for OTC pharmaceuticals, and it is regulated by the Food and Drug Administration (FDA). While the laws governing OTC pharmaceuticals are very strict, the market itself has grown over the years and has many major players operating in the industry.
With market growth mitigating rivalry in the pharma market, manufacturers are focusing on product differentiation in order to make a niche for themselves. This report includes provides a SWOT analysis and product offerings of major industry players including Bristol Myers Squibb, Novartis, Bayer, GlaxoSmithKline, and many others.
With the global OTC pharmaceuticals industry expected to grow at a moderate pace in the coming years, the U.S. OTC pharmaceuticals market is also looking for a decelerated growth till the year 2014.
This research report on the U.S. OTC Pharmaceutical Market analyzes this high-growth industry’s market value and competitive landscape, and includes a U.S. OTC Drug Monograph.
Analysis of the Global OTC Pharmaceuticals Market
Market Definition
Market Overview
Industry Value
Industry Segmentation
Global Market Share
Competitive Landscape
Analysis of Market Share
Industry Outlook
Analysis of the U.S. OTC Pharmaceuticals Market
Market Statistics
Market Overview
Industry Value
Industry Segmentation
Global Market Share
Competitive Landscape
Analysis of Market Share
OTC Sales
OTC Labeling
Industry Outlook
Institutional Framework for OTC Drugs in the U.S.
Overview
OTC Drug Product Review
Pricing & Reimbursement Policy
Promotion to Customers
U.S. OTC Drug Monograph
Overview
What is the OTC Drug Monograph?
Using OTC Monograph for Product Launches
Analysis through Case Study
Conclusion
Major Players
Bayer AG
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc
Sanofi-Aventis SA
Johnson & Johnson
GlaxoSmithKline Plc
GelStat Corporation
Market Definition
Market Overview
Industry Value
Industry Segmentation
Global Market Share
Competitive Landscape
Analysis of Market Share
Industry Outlook
Analysis of the U.S. OTC Pharmaceuticals Market
Market Statistics
Market Overview
Industry Value
Industry Segmentation
Global Market Share
Competitive Landscape
Analysis of Market Share
OTC Sales
OTC Labeling
Industry Outlook
Institutional Framework for OTC Drugs in the U.S.
Overview
OTC Drug Product Review
Pricing & Reimbursement Policy
Promotion to Customers
U.S. OTC Drug Monograph
Overview
What is the OTC Drug Monograph?
Using OTC Monograph for Product Launches
Analysis through Case Study
Conclusion
Major Players
Bayer AG
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc
Sanofi-Aventis SA
Johnson & Johnson
GlaxoSmithKline Plc
GelStat Corporation
